News

Filter

Baxter in up to $565 million deal with Onconova for rigosertib

20-09-2012

US companies Baxter International (NYSE: BAX) and privately-held biotech Onconova Therapeutics have entered…

Baxter InternationalEstybonEuropeLicensingOncologyOnconova TherapeuticsPharmaceuticalrigosertib

COMPANY SPOTLIGHT

Menarini

Back to top